HIV Treatment as Prevention

摘要: Breakthrough of the YearHIV/AIDS researchers have long debated whether antiretroviral drugs (ARVs) used to treat HIV-infected people might a double benefit and cut transmission rates. To some it was obvious: ARVs reduce HIV levels, so individuals should be less infectious. Skeptics contended that this unproven. Then in May year, 052 clinical trial conducted by Prevention Trials Network (HPTN) reported reduced risk heterosexual 96%. Because HPTN 052's profound implications for future response AIDS epidemic, Science has chosen as its Year.